NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs) with small molecules in oncology and neuroscience.
Our proprietary computational engine, combined with deep lncRNA biology expertise and strong drug discovery capabilities, positions us well to unlock the therapeutic value of lncRNAs, a vast and promising target space.
NextRNA has assembled an experienced team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.
Company Details
- Employees
- 31
- Founded
- -
- Address
- 40 Guest St, Boston,massachusetts 02135,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://NextRNATx.com
- Keywords
- strong drug discovery capabilities.
- HQ
- Boston, Massachusetts
Nextrna Therapeutics Questions
Nextrna Therapeutics's website is http://NextRNATx.com
Nextrna Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nextrna-therapeutics
Nextrna Therapeutics has
31 employees.
View email and phone details for 31
employees at Nextrna Therapeutics.
Nextrna Therapeutics's industry is
Biotechnology Research
Nextrna Therapeutics's top competitors are
Mbx Biosciences, Inc.,
Evotec,
Regeneron,
Bicara Therapeutics,
Ipsen,
Haya Therapeutics,
Biomarin Pharmaceutical Inc.,
Bayer,
Vc-Backed Biotech Newco,
Zenas Biopharma.
Nextrna Therapeutics's categories are Biotechnology Research
Nextrna Therapeutics's founding year is 2020
